Trident Lifeline jumps 20% and hits the upper circuit
Trident Lifeline Limited operates in the marketing of pharmaceutical products in both domestic and international markets. The company witnessed a significant surge in its share price today.
At the opening of the trading day, the Trident Lifeline stock started at Rs 171 per share, marking an impressive 4.9% gain from the previous day’s closing price of Rs 163 per share on the BSE. As of the time of composing this article, the stock is currently trading at Rs 195.60 per share, signifying an impressive gain of 20% from its prior closing price. It has reached the upper circuit price limit of 20%, indicating strong demand in the market, with no sellers willing to sell their shares at the current price.
Furthermore, the company’s stock is presently trading at a discount of approximately 22% from its all-time high price of Rs 239.70 per share on the BSE. This suggests that there may be room for potential appreciation in the stock’s value.
The current market capitalization of the company stands at Rs 225 crore, and the stock has generated a return of 36% during the last six months and an impressive 50% return during the last one year.
Stocks’s trading and delivery data:
Incorporated in 2014, Trident Lifeline Limited operates in the marketing of pharmaceutical products in both domestic and international markets. Additionally, the company is involved in the distribution of pharmaceutical products through a third-party distribution network. Trident Lifeline Limited is a component of the Trident Texofab Group.
In the first quarter of FY24, the company reported revenues of Rs 8.64 crore. This represents an impressive 45% YoY increase compared to the same quarter in the previous year when the revenue was Rs 7.85 crore. The company’s operating profit for the quarter stood at Rs 1.76 crore, compared to Rs 1.59 crore in the same quarter of the previous year. The operating profit margin for the company during this quarter was 20%. Shifting our attention to the company’s net profit, it amounted to Rs 1.4 crore, compared to a net profit of Rs 1.4 crore in the same period last year.
The company’s Return on Capital Employed (ROCE) and Return on Equity (ROE) stand at 25% and 24%, respectively, indicating strong financial performance. Additionally, the company’s stocks are currently trading at a Price-to-Earnings (PE) ratio of 31.7 times in the market.
Stock Price Chart (Weekly time frame):
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.